Press release
CPSC in the United States releases and implements the eFiling program for compliance certificates
The Consumer Product Safety Commission (CPSC [https://www.btf-lab.com/btf-testing-chemistry-lab-introduction-product/]) in the United States has issued a supplemental notice (SNPR) proposing rulemaking to revise the 16 CFR 1110 compliance certificate. SNPR suggests aligning the certificate rules with other CPSCs regarding testing and certification, and suggests that CPSCs collaborate with the United States Customs and Border Protection (CBP) to simplify the process of submitting Consumer Product Compliance Certificates (CPC/GCC) through electronic filing (eFiling).The Consumer Product Compliance Certificate is an important document for verifying that a product meets safety standards and needs to enter the US market with the goods. The core of the eFiling program is to simplify the process of submitting consumer product compliance certificates and collect compliance data more efficiently, accurately, and timely through digital tools. CPSC can better assess consumer product risks and quickly identify non compliant products through eFiling, which not only helps to intercept non compliant products in advance at ports, but also accelerates the smooth entry of compliant products into the market.
To improve the eFiling system, CPSC has invited some importers to conduct eFiling Beta testing. Importers invited to participate in Beta testing can submit product compliance certificates electronically through CBP's Electronic Commerce Environment (ACE). CPSC is actively developing an electronic filing (eFiling) program and finalizing the plan. Importers participating in the testing are currently testing the system and preparing to fully launch it. eFiling is expected to be officially implemented in 2025, making it a mandatory requirement.
When filing CPSC electronic records (eFiling), importers should provide at least seven aspects of data information:
1. Finished product identification (can refer to the GTIN entry data of the global trade project code);
2. Safety regulations for each certified consumer product;
3. The production date of the finished product;
4. The manufacturing, production, or assembly location of the finished product, including the name, complete address, and contact information of the manufacturer;
5. The date on which the last test of the finished product met the above consumer product safety regulations;
6. The testing laboratory information on which the certificate depends, including the name, complete address, and contact information of the testing laboratory;
7. Maintain test results and record personal contact information, including name, complete address, and contact information.
As a third-party testing laboratory accredited by the Consumer Products Commission (CPSC) in the United States, BTF provides a one-stop solution for CPC and GCC certification certificates, which can assist US importers in submitting electronic records of compliance certificates.
Media Contact
Company Name: BTF Testing Lab (Shenzhen) Co., Ltd.
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cpsc-in-the-united-states-releases-and-implements-the-efiling-program-for-compliance-certificates]
Country: China
Website: https://www.btf-lab.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CPSC in the United States releases and implements the eFiling program for compliance certificates here
News-ID: 3481042 • Views: …
More Releases from ABNewswire
Alzheimer's Disease Market in the 7MM is projected to reach USD 34 Billion by 20 …
Key players operating in the Alzheimer's disease market include Eisai, Biogen, Changchun Huayang High-tech Co. Ltd., Hoffmann-La Roche, vTv Therapeutics, AZTherapies, Cerecin, Neurotrope, Lyndra, AC Immune, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly, AB Science, Cortexyme, Anavex Life Sciences, Athira Pharma, Time Therapeutics, Prilenia Therapeutics, Denali Therapeutics Inc., Stemedica Cell Technologies, Inc., along with several other emerging and established companies.
The Alzheimer's disease market was valued at approximately USD 3,610 million…
Glaucoma Market Forecast 2034: USD 4,073 Million Market Size, 30+ Companies, and …
Major Glaucoma players include Allergan (AbbVie), Sun Pharma Advanced Research Company Limited, Santen Pharmaceutical Co., Ltd., Alcon, D. Western Therapeutics Institute (DWTI), Kowa Ltd., Senju Pharmaceuticals, Otsuka Pharmaceuticals, Bausch and Lomb, Novartis, Merck & Co., Aerie Pharmaceuticals, Nicox Ophthalmics, Sylentis, Envisia Therapeutics, Ocuphire Pharma, TearClear, Peregrine Ophthalmic, and others.
The Glaucoma Market across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom,…
Graves' Disease Market Size in the 7MM was ~USD 4,400 million in 2023 and is exp …
DelveInsight's "Graves' Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Graves' Disease, historical and forecasted epidemiology as well as the Graves' Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
Explore Graves' Disease Market Trends, treatment landscapes, and emerging therapies shaping the future. Download sample report @ [https://www.delveinsight.com/sample-request/graves-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Graves' Disease Market Report
* In December…
Myelofibrosis Market in the 7MM is projected to grow at a CAGR of 9% by 2034, es …
DelveInsight's 'Myelofibrosis Market Insight, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of myelofibrosis, historical and forecasted epidemiology as well as the myelofibrosis therapeutics market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Discover more about the Myelofibrosis Market in detail @ Myelofibrosis Treatment Market Report @ https://www.delveinsight.com/sample-request/myelofibrosis-mf-market [https://www.delveinsight.com/sample-request/myelofibrosis-mf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Myelofibrosis Market Report
* On January 09, 2026, Swedish Orphan…
More Releases for CPSC
U.S. CPSC Proposes Safety Standard for Infant Inclined Sleep Products
The U.S. Consumer Product Safety Commission (CPSC) has issued a proposal for a new federal regulation: 16 CFR 1236 Safety Standard for Infant Inclined Sleep Products. If adopted, the proposed notice of rulemaking (NPR) will establish a standard and include Infant Inclined Sleep Products in the list of notice of requirements (NOR) released by the CPSC. The proposal clarifies that infant inclined sleep products fall within the category of “durable…
US CPSC Approves Final Rule for Infant Bath Tubs Safety Standard
The U.S. Consumer Product Safety Commission (CPSC) has approved its final rule for an Infant Bath Tubs safety standard with a unanimous vote of 5-0. The safety standard refers to voluntary standard ASTM F2670-17 Standard Consumer Safety Specification for Infant Bath Tubs, as the mandatory federal safety standard for Infant Bath Tubs.
Infant Bath Tubs are defined in ASTM F2670-17 as a “tub, enclosure, or other similar product intended to hold…
US CPSC Adopts New Standard for Baby Sling Carriers
The Consumer Product Safety Commission (CPSC) has voted for and approved 16 CFR 1228 for baby sling carriers with a margin of 3-2. 16 CFR 1228 adopts ASTM F2907-15, a Standard Consumer Safety Specification for Sling Carriers, with one amendment requiring warning labels to be attached to the fabric on all sides of the tag and in a visible position.
ASTM F2907-15 defines a ‘sling carrier’ as ‘‘a product of fabric…
US CPSC Proposes New Standard for Baby Changing Products
The US Consumer Product Safety Commission (CPSC) has issued a draft notice of proposed rulemaking (NPR) relating to safety standards for baby changing products. Issued on August 17, 2016, the proposal seeks to amend 16 CFR part 1112 to include 16 CFR part 1236 in the list of notice of requirements (NORs), issued by the Commission.
The proposed rule is for baby changing products and includes changing tables and other changing…
US CPSC Proposes Mandatory Phthalate Testing Exemption for Certain Plastics
On August 17, 2016, the Consumer Product Safety Commission (CPSC) issued a Notice of Proposed Rulemaking (NPR) relating to the requirement for third party testing for phthalates in specific types of plastic. The CPSC has now given stakeholders a period of 75 days to comment on the proposals before a final rule is made.
Under the Consumer Product Safety Improvement Act of 2008 (CPSIA), manufacturers and importers of childcare articles and…
CPSC Amends Consumer Registration Regulations for Durable Infant Products
With publication of a Final Rule in the Federal Register by the U.S. Consumer Product Safety Commission (CPSC) on February 17, 2012 amending the 16 CFR 1130 requirements for consumer registration of durable infant or toddler products, to clarify and correct some of the requirements and respond to consumer feedback on registration. The rule becomes effective on February 18, 2013.
The amendment addresses Title 16 (commercial practices) of the United States…
